960 x 350_41

Small and Large Molecule LC-MS

Accurately measuring and quantifying biomarkers in relevant matrices informs numerous aspects of clinical drug development. Biomarker assays can match patients to appropriate therapies and demonstrate a candidate drugs safety and efficacy, thus illuminating its potential for clinical and commercial success. Q2 Solutions offers a wide range of tailored and integrated liquid chromatography mass spectrometry services to support biomarker testing and quantitation, including LC/MS bioanalysis, LC/MS/MS analysis, hybrid LC-MS assays, small molecule LC/MS, and large molecule bioanalysis.

Our team has extensive experience developing and validating multiplex LC/MS assays of endogenous analytes (e.g., proteins, peptides, lipids) and small/large molecules and their metabolites. Q2 Solutions’ LC/MS/MS bioanalytical services are GLP and GCP compliant to support FDA, OECD, MHLW, and ICH standards.

Related Thought Leaders Insights

Factsheet

Monoclonal Antibodies Reagents

Specifica, a Q2 Solutions company, is applying its proven platform for antibody discovery to generate recombinant monoclonal antibody reagents. Our in vitro display approach eliminates the need for...

Brochure

ImmunXperts

ImmunXperts, a Q2 Solutions company, provides functional insights into immune-mediated adverse events. We provide in silico and in vitro methods, using T-cell activation and proliferation as a...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...